Seems the best thread for this development. We all know OCC has lots of real world data on ATI after a decade of clinical use. The FDA increasingly willing to look at real world data in regulatory applications. Another small improvement in the likelihood of ATI (and CelGro with growing Special Access Scheme use in tendons and nerve) gaining approval at the FDA....
https://www.fda.gov/drugs/news-events-human-drugs/fda-issues-draft-guidances-real-world-evidence-prepares-publish-more-future
Seems the best thread for this development. We all know OCC has...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
-0.015(3.23%) |
Mkt cap ! $94.30M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.0¢ | 44.8¢ | $101.0K | 221.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6739 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 9799 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| OCC (ASX) Chart |